Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

Tourmaline Oil Corp. is an oil and natural gas company, which engages in the acquisition, exploration, development, and production of petroleum and natural gas properties. It focuses on its program in ...